CN Patent

CN104334560A — (s)-2-(1-(9h-嘌呤-6-基氨基)丙基)-5-氟-3-苯基喹唑啉-4(3h)-酮的多晶型物

Assigned to Gilead Calistoga LLC · Expires 2015-02-04 · 11y expired

What this patent protects

本申请公开了(S)-2-(1-(9H-嘌呤-6-基氨基)丙基)-5-氟-3-苯基喹唑啉-4(3H)-酮的多晶型物、其组合物、其制备方法及其使用方法。

USPTO Abstract

本申请公开了(S)-2-(1-(9H-嘌呤-6-基氨基)丙基)-5-氟-3-苯基喹唑啉-4(3H)-酮的多晶型物、其组合物、其制备方法及其使用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN104334560A
Jurisdiction
CN
Classification
Expires
2015-02-04
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Calistoga LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.